Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes
about
The role of epigenetics in the pathology of diabetic complicationsSkeletal muscle as a therapeutic target for delaying type 1 diabetic complicationsTargeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation?Inflammation determines the pro-adhesive properties of high extracellular d-glucose in human endothelial cells in vitro and rat microvessels in vivoDiabetes propels the risk for cardiovascular disease: sweet monocytes becoming aggressive?The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over timeThe role of macrophage polarization in infectious and inflammatory diseasesRedox regulation of MAPK phosphatase 1 controls monocyte migration and macrophage recruitment.Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot footResting and exercise-induced IL-6 levels in children with Type 1 diabetes reflect hyperglycemic profiles during the previous 3 daysDiabetes is a proinflammatory state: a translational perspective.Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data.Acute suppression of circulating sCD40L during hyperglycemia and euglycemic-hyperinsulinemia in healthy young males.Monocyte gene-expression profiles associated with childhood-onset type 1 diabetes and disease risk: a study of identical twins.Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications.Salivary peptidome in type 1 diabetes mellitus.Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood-brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis.Macrophages and β-cells are responsible for CXCR2-mediated neutrophil infiltration of the pancreas during autoimmune diabetesAlterations of the salivary secretory peptidome profile in children affected by type 1 diabetes.Elevated levels of serum IL-12 and IL-18 are associated with lower frequencies of CD4(+)CD25 (high)FOXP3 (+) regulatory t cells in young patients with type 1 diabetesDiabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature.Interleukin-1β produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: Implications for the timing of tolerizing immunotherapy.Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit.Aberrant Pregnancy Adaptations in the Peripheral Immune Response in Type 1 Diabetes: A Rat Model.Hyperglycemia induces Toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathyIncreased systemic Th17 cytokines are associated with diastolic dysfunction in children and adolescents with diabetic ketoacidosisRestoration of angiogenic capacity of diabetes-insulted mesenchymal stem cells by oxytocin.Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetesKnockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathyHyperketonemia increases monocyte adhesion to endothelial cells and is mediated by LFA-1 expression in monocytes and ICAM-1 expression in endothelial cells.Potential role of IL-17-producing iNKT cells in type 1 diabetes.Inflammatory cytokine profiles during exercise in obese, diabetic, and healthy children.Effect of hyperketonemia (Acetoacetate) on nuclear factor-κB and p38 mitogen-activated protein kinase activation mediated intercellular adhesion molecule 1 upregulation in endothelial cellsLongitudinal Association Between Endothelial Dysfunction, Inflammation, and Clotting Biomarkers With Subclinical Atherosclerosis in Type 1 Diabetes: An Evaluation of the DCCT/EDIC CohortSoluble CD40 ligand contributes to dendritic cell-mediated T-cell dysfunction in HIV-1 infection.Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1.Interleukin-6 (IL-6) mediated the increased contraction of distal colon in streptozotocin-induced diabetes in rats via IL-6 receptor pathwayIncreased Blood Levels of Growth Factors, Proinflammatory Cytokines, and Th17 Cytokines in Patients with Newly Diagnosed Type 1 Diabetes.Uncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award Lecture
P2860
Q24609124-A5FE3129-3E40-4644-8AF6-128C23D749B8Q26775403-1F875E14-28A7-4F60-8DA6-ACB9A023CA74Q27010594-CEE60167-F3AB-4112-8623-8AD2EF951D39Q27331780-97200DBE-396D-4115-93CE-996D508BE069Q28072462-3C729DC3-D41B-4433-B480-E28AE5446B99Q28285897-B5D418E1-B700-442E-A1DF-8F1129A3EB7BQ30413135-5EBF914E-7A16-4A35-9497-401DB1AEA948Q30525793-DE17F2FD-8A13-4F79-B895-B912F6737BBFQ33602274-9D8EEB28-E216-4D26-9160-A7576E7A8716Q33656668-E1D636BD-614E-48A5-BEC3-95D422DC075AQ33693974-1D8CE2E3-62BF-48C7-B420-E415689A003FQ33753663-937F89A9-A025-4CD6-9A73-3C2985969C80Q33768652-E13EA1F3-ABFF-48AF-9CBE-142CE65F8200Q33930285-E2E064BF-0C5D-4897-A28A-5F1ED31AB912Q33937994-17F6EF29-7F9B-40AD-87AD-3253BE76A5A5Q34013080-672C472B-E7F4-414E-9771-205D9188D68BQ34015684-08C2C6D6-63EF-4000-B2CE-2A18B2FCAA13Q34131197-6AF0B25E-C813-4CFD-9FB0-C7AE8BCAE752Q34193612-6E202C05-0E7E-4E5B-A39E-F52C8017AF71Q34240279-0E45BAB5-081B-4CCC-8B34-5F3501629BA1Q34350546-154A21DE-4AA3-4D7C-BE14-62D402F0346DQ34448684-24A65392-9FB6-49AE-825F-0A36AE2B7FC1Q34572620-1DCF4C68-5830-4D14-B0BF-7A1C7E217270Q34629092-F98786E5-903C-4478-9BCD-23B05A679487Q34785213-3BDFF96B-F9B0-48BD-9238-909E044B5F1BQ34950714-3BC99344-7DD2-4BA7-A1FD-0C721A313BCDQ34981029-C22FEDA6-415D-4E71-A0C4-4A77FFF78779Q34984962-DC3677C2-EB18-4109-8381-15264978D7D0Q35140825-9A8BAA15-C818-48A5-9439-806B06739627Q35143026-595F3C47-C2E9-4F41-ACAB-F5288675121BQ35159369-C5B320CD-254A-49E3-8FBC-D2709251152AQ35161591-67D185BE-B019-4AA4-AF83-E7F1340FB5E7Q35251581-28EF0AFB-7304-4E50-9FE1-E245F1FBDD89Q35428861-7C08D37B-9711-4F81-A349-A3E5DDE098C8Q35769521-1FBE0749-9381-418D-984C-6EE737B52DC7Q35772650-C6035DA8-CE24-436E-B714-3028B81412CEQ35849515-F1824457-A7F4-4D93-A1D8-C11E0FECCF83Q35853885-5E5DC613-3CC3-454E-962F-52C26DC744CEQ35860851-58DD56D2-BC40-4B60-9993-025E8D52CCBCQ35881759-C901479B-2429-4B41-B947-4C85CCD6208F
P2860
Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Increased monocytic activity a ...... patients with type 1 diabetes
@ast
Increased monocytic activity a ...... patients with type 1 diabetes
@en
Increased monocytic activity a ...... patients with type 1 diabetes
@nl
type
label
Increased monocytic activity a ...... patients with type 1 diabetes
@ast
Increased monocytic activity a ...... patients with type 1 diabetes
@en
Increased monocytic activity a ...... patients with type 1 diabetes
@nl
prefLabel
Increased monocytic activity a ...... patients with type 1 diabetes
@ast
Increased monocytic activity a ...... patients with type 1 diabetes
@en
Increased monocytic activity a ...... patients with type 1 diabetes
@nl
P2093
P921
P3181
P1433
P1476
Increased monocytic activity a ...... patients with type 1 diabetes
@en
P2093
Eric Miguelino
Ishwarlal Jialal
Janice Wang-Polagruto
Nicole Glaser
Sridevi Devaraj
Steve Griffen
P3181
P356
10.2337/DIABETES.55.03.06.DB05-1417
P407
P577
2006-03-01T00:00:00Z